No Data
No Data
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersJanux Therapeutics (NASDAQ:JANX) stock increased by 189.9% to $43.78 during Tuesday's regular session. The company's market cap stands at $2.0 billion. Viking Therapeutics (NASDAQ:VKTX) shares
Qualigen Therapeutics Secures Investment and Expands Financing Options
Qualigen Therapeutics Inks Exclusive RAS Program Deal
Express News | Qualigen Therapeutics New Publication Released In The Nature Scientific Reports Journal Titled "Structure–Activity Relationships For The G-Quadruplex-Targeting Experimental Drug QN-302 And Two Analogues Probed With Comparative Transcriptome Profiling And
Qualigen Therapeutics Provides Corporate Update For Q3 And To Date 2023
Initiated dosing of three patients in first cohort of Phase 1 clinical trial of QN-302 for treatment of advanced or metastatic solid tumorsPhase 1a patient recruitment ongoing; company anticipates sha
Qualigen Therapeutics Announces First Patient Dosed In The Phase 1a Clinical Trial Of QN-302 For Treatment Of Advanced Or Metastatic Solid Tumors
Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announces
No Data